These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3740362)

  • 1. A saphenous alternative: preferential use of superficial femoral and popliteal veins as femoropopliteal bypass grafts.
    Schulman ML; Badhey MR; Yatco R; Pillari G
    Am J Surg; 1986 Aug; 152(2):231-7. PubMed ID: 3740362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study.
    Schulman ML; Badhey MR; Yatco R
    J Vasc Surg; 1987 Jul; 6(1):1-10. PubMed ID: 3599276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 11-year experience with deep leg veins as femoropopliteal bypass grafts.
    Schulman ML; Badhey MR; Yatco R; Pillari G
    Arch Surg; 1986 Sep; 121(9):1010-5. PubMed ID: 3741095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoropopliteal bypass for claudication: vein vs. PTFE.
    Allen BT; Reilly JM; Rubin BG; Thompson RW; Anderson CB; Flye MW; Sicard GA
    Ann Vasc Surg; 1996 Mar; 10(2):178-85. PubMed ID: 8733871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoropopliteal composite dacron and autogenous vein bypass grafts. A preliminary report.
    Linton RR; Wirthlin LS
    Arch Surg; 1973 Nov; 107(5):748-53. PubMed ID: 4270358
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of lower extremity deep veins as arterial substitutes: functional status of the donor leg.
    Schanzer H; Chiang K; Mabrouk M; Peirce EC
    J Vasc Surg; 1991 Nov; 14(5):624-7. PubMed ID: 1942370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts.
    Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M
    Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?
    Quiñones-Baldrich WJ; Busuttil RW; Baker JD; Vescera CL; Ahn SS; Machleder HI; Moore WS
    J Vasc Surg; 1988 Sep; 8(3):219-28. PubMed ID: 3418827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators in femoropopliteal and distal bypass grafts.
    Barry R; Satiani B; Mohan B; Smead WL; Vaccaro PS
    Surg Gynecol Obstet; 1985 Aug; 161(2):129-32. PubMed ID: 4023893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft type for femoro-popliteal bypass surgery.
    Ambler GK; Twine CP
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion.
    Kim SY; Min SK; Ahn S; Min SI; Ha J; Kim SJ
    J Vasc Surg; 2012 Jan; 55(1):90-7. PubMed ID: 21944915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ femoral to popliteal bypass graft using superficial femoral vein to popliteal vein.
    Pfeiffer RB; Pfeiffer RB; Esses GE; Watts B
    Am Surg; 2004 Jul; 70(7):617-9. PubMed ID: 15279186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoral-popliteal bypass with endoscopically harvested saphenous vein in patients with TASC D disease of the superficial femoral artery.
    Hines GL; Wain RA; Montecalvo J; Feuerman M
    Ann Vasc Surg; 2010 Jul; 24(5):615-20. PubMed ID: 19892513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft type for femoro-popliteal bypass surgery.
    Mamode N; Scott RN
    Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments.
    Kram HB; Gupta SK; Veith FJ; Wengerter KR; Panetta TF; Nwosisi C
    J Vasc Surg; 1991 Sep; 14(3):386-90. PubMed ID: 1880847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study.
    Johnson WC; Lee KK
    J Vasc Surg; 2000 Aug; 32(2):268-77. PubMed ID: 10917986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
    Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
    J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study.
    Taheri SA
    J Vasc Surg; 1987 Dec; 6(6):624-5. PubMed ID: 3694762
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic entrapment of femoropopliteal saphenous vein bypass grafts by the gastrocnemius muscle.
    Brener BJ; Alpert J; Brief DK; Parsonnet V
    Surgery; 1975 Nov; 78(5):668-74. PubMed ID: 1188609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.